Human immunodeficiency virus dementia: Evidence of a subcortical process from studies of fine finger movements

Journal of NeuroVirology

Volumn 8, Issue SUPPL. 2, 2002, Pages 27-32

  Arendt, Gabriele ^a   von Giesen, Hans Jürgen ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Basal ganglia; Electrophysiological motor testing; HIV 1 associated dementia; HIV 1 associated minor motor deficits; Subcortical dementia

Indexed keywords

ANTIRETROVIRUS AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BASAL GANGLION; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; COGNITIVE DEFECT; DEATH; DEMENTIA; DISEASE ASSOCIATION; DISEASE COURSE; EMOTIONAL DISORDER; FINGER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; REVIEW;

AIDS DEMENTIA COMPLEX; BASAL GANGLIA; FINGERS; HUMANS; MOVEMENT; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0036948029     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280290101067     Document Type: Review

References (54)

1. Arendt G (1994). Die Bedeutung quantifizierender elektrophysiologischer Parameter für die Erfassung er Verlaufskinetik HIV assoziierter zerebraler Erkrankungen. Habilitationsschrift der Medizinischen Fakultät, Heinrich-Heine-Universität Düsseldorf: Düsseldorf.
2. Arendt G, Hefter H, Buescher L, Hilperath F, Elsing C, Freund HJ (1992). Improvement of motor performance of HIV-positive patients under AZT therapy. Neurology 42: 891-896.
3. Arendt G, Hefter H, Elsing C, Strohmeyer G, Freund HJ (1990). Motor dysfunction in HIV-infected patients without clinically detectable central-nervous deficit. J Neurol 237: 362-368.
4. Arendt G, Hefter H, Hilperath F, von Giesen HJ, Strohmeyer G, Freund HJ (1994a). Motor analysis predicts progression in HIV-associated brain disease. J Neurol Sci 123: 180-185.
5. Arendt G, Hefter H, Neuen-Jacob E, Wist S, Kuhlmann H, Strohmeyer G, Freund H-J (1993). Electrophysiological motor testing, MRI findings and clinical course in AIDS patients with dementia. J Neurol 240: 439-445.
6. Arendt G, Maecker HP, Purrmann J, Homberg V (1994b). Control of posture in patients with neurologically asymptomatic HIV infection and patients with beginning HIV-1-related encephalopathy. Arch Neurol 51: 1232-1235.
7. Arendt G, von Giesen HJ, Hefter H, Theisen A (2001). Therapeutic effects of nucleoside analogues on psychomotor slowing in HIV infection. AIDS 15: 493-500.
8. Aylward EH, Henderer JD, McArthur JC, Brettschneider PD, Harris GJ, Barta PE, Pearlson GD (1993). Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology 43: 2099-2104.
9. Aylward EH, Roberts-Twillie JV, Barta PE, Kumar AJ, Harris GJ, Geer M, Peyser CE, Pearlson GD (1994). Basal ganglia volumes and white matter hyperintensities in patients with bipolar disorder. Am J Psychiatry 151: 687-693.
10. Baldeweg T, Gruzelier JH, Catalan J, Pugh K, Lovett E, Riccio M, Stygall J, Irving G, Catt S, Hawkins D (1993a). Auditory and visual event-related potentials in a controlled investigation of HIV infection. Electroencephal Clin Neurophysiol 88: 356-368.
11. Baldeweg T, Gruzelier JH, Stygall J, Lovett E, Pugh K, Liddiard D, Müller J, Riccio M, Hawkins D, Catalan J (1993b). Detection of subclinical motor dysfunctions in early symptomatic HIV infection with topographical EEG. Int J Psychophysiol 15: 227-238.
12. Beckley DJ, Bloem BR, Martin EM, Panzer VP, Remler MP (1998). Postural reflexes in patients with HIV-1 infection. Electroencephal Clin Neurophysiol 109: 402-408.
13. Berger JR, Arendt G (2000). HIV dementia: the role of the basal ganglia and dopaminergic systems. J Psychopharmacol 14: 214-221.
14. Berger JR, Kumar M, Kumar A, Fernandez JB, Levin B (1994). Cerebrospianl fluid dopamine in HIV-1 infection. AIDS 8: 67-71.
15. Berger JR, Nath A (1997). HIV dementia and the basal ganglia. Intervirology 40: 122-131.
16. Bornstein RA, Nasrallah HA, Para MF, Whitacre CC, Rosenberger P, Fass RJ, Rice R Jr (1992). Neuropsychological performance in asymptomatic HIV infection. J Neuropsychiatry Clin Neurosci 4: 386-394.
17. Bornstein RA, Pace P, Rosenberger P, Nasrallah HA, Para MF, Whitacre CC, Fass RJ (1993). Depression and neuropsychological performance in asymptomatic HIV infection. Am J Psychiatry 150: 922-927.
18. Brew BJ, Bhalla RB, Paul M, Gallardo H, McArthur JC, Schwartz MK, Price RW (1990). Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection. Ann Neurol 28: 556-560.
19. Brew BJ, Rosenblum M, Cronin K, Price RW (1995). AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann Neural 38: 563-570.
20. Chang L, Ernst T, Leonido-Yee M, Walot I, Singer E (1999). Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex. Neurology 52: 100-108.
21. Dal Pan GJ, McArthur JH, Aylward E, Selnes OA, Nance-Sproson TE, Kumar AJ, Mellits ED, McArthur JC (1992). Patterns of cerebral atrophy in HIV-1-infected individuals: results of a quantitative MRI analysis. Neurology 42: 2125-2130.
22. Day JJ, Grant I, Atkinson JH, Brysk LT, McCutchan JA, Hesselink JR, Heaton RK, Weinrich JD, Spector SA, Richman DD (1992). Incidence of AIDS dementia in a two-year follow-up of AIDS and ARC patients on an initial phase II AZT placebo-controlled study: San Diego cohort. J Neuropsychiatry Clin Neurosci 4: 15-20.
23. Dunlop O, Bjorklund RA, Abdelnoor M, Myrvang B (1992). Five different tests of reaction time evaluated in HIV seropositive men. Acta Neurol Scand 86: 260-266.
24. Filippi CG, Sze G, Farber SJ, Shahmanesh M, Selwyn PA (1998). Regression of HIV encephalopathy and basal ganglia signal intensity abnormality at MR imaging in patients with AIDS after the initiation of protease inhibitor therapy. Radiology 206: 491-498.
25. Janssen RS, Saykin AJ, Cannon L, Campbell J, Pinsky PF, Hessol NA, O'Malley PM, Lifson AR, Doll LS, Rutherford GW, Kaplan JE (1989). Neurological and neuropsychological manifestations of HIV-1 infection: association with AIDS-related complex but not asymptomatic HIV-1 infection. Ann Neurol 26: 592-600.
26. Karlsen NR, Reinvang I, Froland SS (1992). Slowed reaction time in asymptomatic HIV-positive patients. Acta Neurol Scand 86: 242-246.
27. Kure K, Weidenheim KM, Lyman WD, Dickson DW (1990). Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration. Acta Neuropathol 80: 393-400.
28. Lu D, Pavlakis S, Frank Y, Bakshi S, Pahwa S, Gould RJ, Sison C, Hsu C, Lesser M, Hoberman M, Barnett T, Hyman RA (1996). Proton MR spectroscopy of the basal ganglia in healthy children and children with AIDS. Radiology 199: 423-428.
29. McAllister RH, Herns MV, Harrison MJ, Newman SP, Connolly S (1992). Neurological and neuropsychological performance in HIV seropositive men without symptoms. J Neurol Neurosurg Psychiatry 55: 143-148.
30. McArthur JC (1987). Neurologic manifestations of AIDS. Medicine 66: 407-437.
31. McArthur JC, Hoover DR, Bacellar H, Miller EN, Cohen BA, Becker JT, Graham NM, McArthur JH, Selnes OA, Jacobson LP, et al (1993). Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 43: 2245-2252.
32. McArthur JH, McArthur JC (1986). Neurological manifestations of acquired immunodeficiency syndrome. J Neurosci Nurs 18: 242-249.
33. Meyerhoff DJ, Bloomer C, Cardenas V, Norman D, Weiner MW, Fein G (1999). Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients. Neurology 52: 995-1003.
34. Meyerhoff DJ, MacKay S, Bachman L, Poole N, Dillon WP, Weiner MW, Fein G (1993). Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: in vivo 1H magnetic resonance spectroscopic imaging. Neurology 43(3pt 1): 509-515.
35. Nath A, Jankovic J (1989). Motor disorders in patients with human immunodeficiency virus infection. Prog AIDS Pathol 1: 159-166.
36. Navia BA, Cho E-S, Petito CK, Price RW (1986a). The AIDS dementia complex: II. Neuropathology. Ann Neurol 19: 525-535.
37. Navia BA, Jordan BD, Price RW (1986b). The AIDS dementia complex: I. Clinical features. Ann Neurol 19: 517-524.
38. Neuen-Jacob E, Arendt G, Wendtland B, Jacob B, Schneeweis M, Wechsler W (1993). Frequency and topographical distribution of CD68-positive macrophages and HIV-1 core proteins in HIV-associated brain lesions. Clin Neuropathol 12: 315-324.
39. Portegies P, de Gans J, Lange JM, Derix MM, Speelman H, Bakker M, Danner SA, Goudsmit J (1989). Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. BMJ 299: 819-821.
40. Reyes MG, Faraldi F, Senseng CS, Flowers C, Fariello R (1991). Nigral degradation in acquired immune deficiency syndrome (AIDS). Acta Neuropathol 82: 39-44.
41. Rottenberg DA, Moeller JR, Strother SC, Sidtis JJ, Navia BA, Dhawan V, Ginos JZ, Price RW (1987). The metabolic pathology of the AIDS dementia complex. Ann Neurol 22: 700-706.
42. Rottenberg DA, Sidtis JJ, Strother SC, Schaper KA, Anderson JR, Nelson MJ, Price RW (1996). Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia. J Nucl Med 37: 1133-1141.
43. Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC (2001). HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 56: 257-260.
44. Sacktor NC, Bacellar H, Hoover DR, Nance-Sproson TE, Selnes OA, Miller EN, Dal Pan GJ, Kleeberger C, Brown A, Saah A, McArthur JC (1996). Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death. J NeuroVirol 2: 404-410.
45. Sacktor NC, Lyles RH, Skolasky RL, Anderson DE, McArthur JC, McFarlane G, Selnes OA, Becker JT, Cohen B, Wesch J, Miller EN (1999). Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men. Multicenter AIDS Cohort Study (MACS). Neurology 52: 1640-1647.
46. Schmitt FA, Bigley JW, McKinnis R, Logue PE, Evans RW, Drucker JL (1988). Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. N Engl J Med 319: 1573-1578.
47. Sidtis JJ, Gatsonis C, Price RW, Singer EJ, Collier AC, Richman DD, Hirsch MS, Schaerf FW, Fischl MA, Kieburtz K, Simpson D, Koch MA, Feinberg J, Dafni U, AIDS Clinical Trial Group (1993). Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. Ann Neurol 33: 343-349.
48. Snider W, Simpson D, Nielsen S, Gold J, Metroka C, Posner J (1983). Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 14: 403-418.
49. Turjanski N, Sawle GV, Playford ED, Weeks R, Lammerstma AA, Lees AJ, Brooks DJ (1994). PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndromre. J Neurol Neurosurg Psychiatry 57: 688-692.
50. van Gorp WG, Mandelkern MA, Gee M, Hinkin CH, Stern CE, Paz DK, Dixon W, Evans G, Flynn F, Frederick CJ, et al (1992). Cerebral metabolic dysfunction in AIDS: findings in a sample with and without dementia. J Neuropsychiatry Clin Neurosci 4: 280-287.
51. von Giesen HJ, Antke C, Hefter H, Wenserski F, Seitz RJ, Arendt G (2000a). Potential time course of human immunodeficiency virus type 1-associated minor motor deficits: electrophysiologic and positron emission tomography findings. Arch Neurol 57: 1601-1607.
52. von Giesen HJ, Hefter H, Jablonowski H, Arendt G (2000b). HAART is neuroprophylactic in HIV-1 infection. J Acquir Immune Defic Syndr 23: 380-385.
53. von Giesen HJ, Koller H, Theisen A, Arendt G (2002). Therapeutic effects of nonnucleoside reverse transcriptase inhibitors on the central nervous system in HIV-1-infected Patients. J Acquir Immune Defic Syndr 29: 363-367.
54. von Giesen HJ, Wittsack HJ, Wenserski F, Köller H, Hefter H, Arendt G (2001). Basal ganglia metabolite abnormalities in HIV-1 associated minor motor deficits. Arch Neurol 58: 1281-1286.